HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Also in Global Health News: HIV/AIDS grant giving; Africa's water resources; sex workers in Malawi

HIV/AIDS program grants made by U.S.-based foundations totaled $618 billion in 2008, an 11 percent increase from the previous year, according to a new report by Funders Concerned About AIDS, the Chronicle of Philanthropy reports. The Bill & Melinda Gates Foundation accounted for the majority of the grants, and when it was "excluded, foundation giving [for HIV/AIDS] actually declined 3 percent compared to 2007."

19 Nov 2009

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.

19 Nov 2009

UNGASS monitoring system provides the overall progress in the global response to HIV

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic. An update on the development of the UN General Assembly Special Session on HIV/AIDS (UNGASS) global reporting system appears in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes.

19 Nov 2009

Data from Phase 1 safety study of SB-728-T announced

Sangamo BioSciences, Inc. announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were inadvertently and prematurely disclosed on the internet.

19 Nov 2009

Opinions: Fighting TB; currency transaction tax

Though tuberculosis "is one of the world's leading killers … few citizens, scientists and policymakers are demanding more attention to TB research, treatment and prevention. … It's time to bring TB research into the 21st century," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, writes in an MSNBC opinion piece.

19 Nov 2009

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.

18 Nov 2009

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.

18 Nov 2009

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.

18 Nov 2009

MSF's volunteer physicians receive free access to Elsevier's electronic CDS tool

The physicians of the world renowned Doctors Without Borders/Medecins Sans Frontieres (MSF), which won the Nobel Peace Prize in 1999, will receive free access to MD Consult (www.mdconsult.com), Elsevier's premier electronic clinical decision support (CDS) tool, as the result of a special new Elsevier campaign.

18 Nov 2009

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

Chembio Diagnostics, Inc., a company that develops, manufactures, licenses, and markets proprietary rapid diagnostic tests, announced today that it will present at a meeting of the Blood Products Advisory Committee ("BPAC") of the U.S. Food and Drug Administration ("FDA") in Bethesda, Maryland, on the afternoon of November 17, 2009.

18 Nov 2009

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease.

18 Nov 2009

Accurate diagnostic tests required to fight against major infectious disease

A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. However, a team headed by Dr. Madhukar Pai at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University in collaboration with researchers at the TDR* and the WHO*, has highlighted the poor quality of published studies that evaluate the accuracy of diagnostic tests for 3 major killer infectious diseases (TB, HIV/AIDS and malaria).

18 Nov 2009

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

Health, policy experts gather for 3-day conference on family planning

By offering family planning services to people seeking HIV/AIDS information and treatment, Africa's population growth rate could be curbed by 2.5 percent, health experts said Monday during an international family health conference in Kampala, Uganda, Agence France-Presse reports (11/16).

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports.

17 Nov 2009

AIDS advocates ask White House to send money south

WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).

17 Nov 2009

HIV/AIDS News and Research

Further Reading

Also in Global Health News: HIV/AIDS grant giving; Africa's water resources; sex workers in Malawi

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

UNGASS monitoring system provides the overall progress in the global response to HIV

Data from Phase 1 safety study of SB-728-T announced

Opinions: Fighting TB; currency transaction tax

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

MSF's volunteer physicians receive free access to Elsevier's electronic CDS tool

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

Accurate diagnostic tests required to fight against major infectious disease

Regulatory agencies offer marketing approval for new products to treat neglected diseases

Health, policy experts gather for 3-day conference on family planning

Global Alliance for Chronic Diseases announces targets

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

AIDS advocates ask White House to send money south

Business professors available for expert commentary on how PPPs can help fight HIV/AIDS

Researchers study different plant substances to "awaken" the latent HIV-1 virus

New proposal can have substantial implications on EU fertility treatment costs

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News